Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
229.00
-10.55 (-4.4%)
BSENSE

Sep 25, 03:30 PM

BSE+NSE Vol: 810

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BDH Industries
Sanjiv.Parant.
Coral Labs.
Medico Remedies
Gennex Lab.
Zenotech Lab.
Nectar Lifesci.
Everest Organics
Kerala Ayurveda
Accretion Pha.
Sat Kartar Life

Why is Everest Organics Ltd ?

1
Weak Long Term Fundamental Strength with a -5.58% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.52 times
  • The company has been able to generate a Return on Equity (avg) of 2.02% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 26
  • INTEREST(9M) At Rs 5.62 cr has Grown at 52.30%
  • PAT(9M) At Rs 4.10 cr has Grown at -24.91%
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.65 cr
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) generated negative returns of -2.22% in the last 1 year, its fall in the stock was much higher with a return of -44.39%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Everest Organics for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Everest Organics
-44.39%
-0.70
63.13%
Sensex
-8.95%
-0.66
13.60%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.11%
EBIT Growth (5y)
-5.58%
EBIT to Interest (avg)
0.50
Debt to EBITDA (avg)
14.38
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
1.82
Tax Ratio
29.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
2.12%
ROE (avg)
2.02%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
43
Industry P/E
38
Price to Book Value
3.03
EV to EBIT
21.13
EV to EBITDA
14.10
EV to Capital Employed
2.23
EV to Sales
1.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
10.68%
ROE (Latest)
6.97%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
ROCE(HY)

Highest at 11.62%

DEBT-EQUITY RATIO(HY)

Lowest at 0.66 times

-12What is not working for the Company
INTEREST(9M)

At Rs 5.62 cr has Grown at 52.30%

PAT(9M)

At Rs 4.10 cr has Grown at -24.91%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 0.65 cr

Loading Valuation Snapshot...

Here's what is working for Everest Organics

Debt-Equity Ratio - Half Yearly
Lowest at 0.66 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Everest Organics

Profit After Tax (PAT) - Quarterly
At Rs 1.11 cr has Fallen at -20.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.39 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Latest six months
At Rs 4.39 cr has Grown at 78.46%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.65 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Footer loading